Targets in psychiatric and neurologic diseases Partnering Program - Biowebspin | Biowebspin
Logo Biowebspin

Targets in psychiatric and neurologic diseases Partnering Program

Deadline December 15th

You have identified or are working on molecular target or compound in psychiatric and neurologic diseases.
You are looking for industrial collaboration or fundings.

Biowebspin will introduce your project to a well-known pharmaceutical company who is currently looking for new opportunities
But also bring your projects to the attention of other major pharma, biotech and medtech companies.

What are our partner looking for?

“Molecular targets and compounds in psychiatric and neurologic diseases” such as mood disorders (i.e., depression, bipolar disorder), psychoses (schizophrenia), disorders of sleep or similar. At the preclinical stage, selected molecular targets must be supported by clear scientific data deriving from in vitro, ex vivo, or animal models. Molecular targets identified in clinical trials (up to Phase II clinical trial) shall also be considered, but the compounds under investigation must be first in the class and not available as marketed drugs

What our partner is offering

Our partner, a well-known pharmaceutical company, 5000+ employees worldwide, is currently doing a first screening to identify new interesting projects for the development of new drugs. After the reviewing stage, our partner will enter into discussion with selected candidate(s), potentially leading to funding and partnership agreements. Our partner is an experienced partner with a long tradition of successful and reliable global partnerships. If your project is selected for collaboration, you may be given an opportunity to use innovative technologies, complementary expertise and resources.

What will Biowebspin also do?

Biowebspin will bring your projects to the attention of major pharma, biotech and medtech companies from its network of 50,000 companies worldwide. Your project will be posted on the partnering platform dedicated to Novel Targets. Industrials will contact you if they are interested in your research.

How does it work?

1 You are an academic researcher, a research group, a small biotech or a technology transfer office? You have a project on new molecular target at an early stage of development (preclinical up to clinical phase II)
Submit your research project in a 30 line short industry like form!
Click here to see an example of project posted.
Note: All submitted information should not be confidential. Our partner will review all submitted information for a first evaluation. When asking for confidential data, our partner will agree a Confidential Disclosure Agreement (CDA) with you.
2 Your project will be reviewed by Biowebspin’s team to see if any information is missing and then send to our partner R&D team that will assess it and come back to you if they are interested.
3 Your research project will also be promoted on the online partnering platform dedicated to Novel targets.
You will be connected as soon as an industrial shows interest in your project.
This program is free of charge and your information will be treated as secure and private.

About us

Biowebspin is the leading life sciences network with more than 2 million researchers in Biotech, Pharma and Medtech including 300,000 industrials looking for partnering and financing academic research projects.

You have projects with industrial application on other topics?

Biowebspin has a network of 50,000 companies working on 5,000 different R&D projects in more than 50 topics, organized in 9 main categories of partnering programs.
Check if one program will fit your researches for industrial collaboration and funding.

Our team members would be pleased to answer all your questions


Guillaume Habault
Project Coordinator

Claire Rochat
Project Assistant

Julien Raynaud
Partnership and Business Director

More informationFollow the last cooperations in R&D and clinical (on Biowebspin Hub) Last reports and publications about types of cooperation between academia and industry

Privacy, intellectual property & confidentiality

Biowebspin pays a lot of attention to the privacy, intellectual property, confidentiality and security of its member data.

Biowebspin is a matchmaking platform between academia & industry. Biowebspin is not involved in the IP discussion and is not charging any success or license fees.
Your «Open Innovation» opportunities on Biowebspin are only visible by industrials and the Biowebspin team. You can remove your data at any time. Biowebspin strongly recommends that you do not enter any confidential data or if you do so, that your technology transfer office agrees the submission of your pre-proposal on Biowebspin. If you directly submit your pre-proposal on an industrial partner website, you will agree their terms, conditions and privacy policy of our industrial partner website. Biowebspin is not responsible for the content, accuracy, or opinion of its industrial partner website.
As a Swiss International company, Biowebspin has high standard security and privacy system. Biowebspin is in accordance with the Federal Data Protection and Information Commissioner.
Check here the terms and conditions of the matchmaking service of Biowebspin.
Check here the terms and the privacy policy of Biowebspin website

Technology Transfer Offices: Become a Partner

Post your Partnering or Licensing Opportunities. We will promote it up to 300,000 industrials and you will be able access Biowebspin company database of 50,000 companies in Biotech, Pharma and Medtech for free. Contact us to know more.